XWELL's balance sheet contracted significantly with total assets declining from $25.4M to $11.2M while liabilities increased, indicating substantial financial deterioration.
The company faces mounting financial stress as evidenced by the sharp reduction in current assets alongside rising current liabilities, creating potential liquidity concerns. The substantial increase in outstanding shares from 5.3M to 7.9M suggests recent equity dilution, likely reflecting emergency capital raising efforts to address the deteriorating financial position.
XWELL's financial profile weakened considerably, with total assets falling 55.8% to $11.2M while total liabilities rose 35.1% to $23.8M, compressing the company's equity cushion. Current assets dropped 61.5% while current liabilities increased nearly 40%, creating a concerning liquidity dynamic. Despite reducing total debt by $2.1M, interest expense grew substantially, and the company increased capital expenditures to $3.0M, suggesting continued investment amid financial constraints.
Capital expenditure jumped 66.2% — major investment cycle underway; assess returns on deployment.
Current assets declined 61.5% — monitor working capital adequacy and short-term liquidity.
Interest expense surged 58.7% — significant debt increase or rising rates materially impacting earnings.
Total assets contracted 55.8% — asset sales, write-downs, or balance sheet optimization underway.
Cash declined 42.5% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
R&D spending cut 41.2% — could signal cost discipline or concerning reduction in innovation investment.
Current liabilities surged 39.8% — significant near-term obligations; verify ability to meet short-term debt.
Debt reduced 36.6% — deleveraging strengthens balance sheet and reduces financial risk.
Liabilities grew 35.1% — significant increase in debt or obligations, assess impact on financial flexibility.
SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →